Tagged liquid-biopsy
Press Release
Universal DX Presents Data at EACR Virtual Congress; Top-Scoring Poster Shows Accurate Detection of Colorectal Advanced Adenomas
New results from the OMICS study, the company's prospective, international, multi-center study, show Universal DX's blood test can detect colorectal advanced adenomas at 55% sensitivity and 90% specificity, which exceeds currently available non-invasive tests for colorectal cancer screening 80% of sporadic colorectal cancers arise from pre-malignant advanced adenomas, making early detection critical to saving lives Read More
Press Release
Cancer Prevention and Early Detection Are One Step Closer as Universal DX Announces Breakthrough Study Results From Its Multi-Omics + Computational Biology + ML Blood Test
New results from the OMICS study, which will be presented at ASCO, show Universal DX's blood test can detect colorectal cancer with extraordinary accuracy (92% sensitivity/97% specificity), which exceeds currently available non-invasive tests for colorectal cancer screening. Early detection cancer screening via a liquid biopsy is not only critical to save lives, but is a vast market opportunity, ranging between $30B and $75B in the U.S. alone Read More
Press Release
